Integrated BioPharma, Inc. (INBP)

Integrated BioPharma Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Net Income	-0.03	3.84	8.01	4.11	1.69
Depreciation & Amortization	1.15	0.83	0.83	0.77	0.77
Share-Based Compensation	0.32	0.37	0.23	0.06	0.14
Other Operating Activities	-0.21	-0.95	-6.02	-3.6	-2.28
Operating Cash Flow	1.23	4.09	3.05	1.34	0.33
Operating Cash Flow Growth	-69.89%	34.13%	127.78%	308.23%	-71.92%
Capital Expenditures	-0.12	-0.49	-0.3	-0.21	-0.41
Acquisitions	0	0.02	0.1	0.1	-0.01
Change in Investments	-0.01	-	-0.29	-0.1	-0.02
Other Investing Activities	0.01	-	0.29	0.1	0.02
Investing Cash Flow	-0.11	-0.47	-0.2	-0.11	-0.42
Common Stock Issued	0	0.03	0.1	0.1	0.02
Other Financing Activities	-0.14	-3.54	-3.14	-1.4	0.32
Financing Cash Flow	-0.14	-3.51	-3.04	-1.3	0.34
Net Cash Flow	0.99	0.12	-0.19	-0.07	0.25
Free Cash Flow	1.12	3.61	2.76	1.13	-0.09
Free Cash Flow Growth	-69.04%	30.85%	144.89%	-	-
Free Cash Flow Margin	2.20%	6.41%	4.33%	2.13%	-0.17%
Free Cash Flow Per Share	0.04	0.11	0.09	0.04	-0.00

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.